Ameriprise’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.61B | Sell |
26,470,718
-1,587,938
| -6% | -$92.6M | 0.37% | 46 |
|
|
2025
Q4 | $1.51B | Sell |
28,058,656
-4,415,178
| -14% | -$212M | 0.34% | 51 |
|
|
2025
Q3 | $1.46B | Sell |
32,473,834
-105,784
| -0.3% | -$4.94M | 0.34% | 48 |
|
|
2025
Q2 | $1.51B | Buy |
32,579,618
+432,158
| +1% | +$21.2M | 0.37% | 45 |
|
|
2025
Q1 | $1.96B | Buy |
32,147,460
+68,214
| +0.2% | +$3.98M | 0.53% | 28 |
|
|
2024
Q4 | $1.81B | Buy |
32,079,246
+12,011,983
| +60% | +$671M | 0.47% | 34 |
|
|
2024
Q3 | $1.04B | Buy |
20,067,263
+2,403,968
| +14% | +$113M | 0.27% | 73 |
|
|
2024
Q2 | $734M | Sell |
17,663,295
-2,100,379
| -11% | -$94M | 0.2% | 106 |
|
|
2024
Q1 | $1.07B | Sell |
19,763,674
-7,980,437
| -29% | -$407M | 0.3% | 66 |
|
|
2023
Q4 | $1.43B | Buy |
27,744,111
+1,982,050
| +8% | +$104M | 0.43% | 42 |
|
|
2023
Q3 | $1.49B | Sell |
25,762,061
-976,093
| -4% | -$59.8M | 0.49% | 31 |
|
|
2023
Q2 | $1.71B | Buy |
26,738,154
+653,888
| +3% | +$43.8M | 0.54% | 28 |
|
|
2023
Q1 | $1.81B | Buy |
26,084,266
+2,439,814
| +10% | +$172M | 0.59% | 24 |
|
|
2022
Q4 | $1.7B | Sell |
23,644,452
-996,976
| -4% | -$75.2M | 0.58% | 27 |
|
|
2022
Q3 | $1.76B | Sell |
24,641,428
-436,501
| -2% | -$31.7M | 0.65% | 21 |
|
|
2022
Q2 | $1.93B | Sell |
25,077,929
-1,750,042
| -7% | -$133M | 0.67% | 18 |
|
|
2022
Q1 | $1.95B | Sell |
26,827,971
-1,154,799
| -4% | -$77.5M | 0.58% | 27 |
|
|
2021
Q4 | $1.73B | Sell |
27,982,770
-508,261
| -2% | -$29.8M | 0.48% | 35 |
|
|
2021
Q3 | $1.69B | Sell |
28,491,031
-1,724,907
| -6% | -$114M | 0.54% | 28 |
|
|
2021
Q2 | $2.02B | Sell |
30,215,938
-36,343
| -0.1% | -$2.37M | 0.62% | 22 |
|
|
2021
Q1 | $1.91B | Buy |
30,252,281
+1,498,152
| +5% | +$93.2M | 0.63% | 22 |
|
|
2020
Q4 | $1.78B | Sell |
28,754,129
-640,901
| -2% | -$39.4M | 0.63% | 22 |
|
|
2020
Q3 | $1.77B | Sell |
29,395,030
-2,128,869
| -7% | -$128M | 0.72% | 20 |
|
|
2020
Q2 | $1.85B | Buy |
31,523,899
+1,363,804
| +5% | +$81.6M | 0.79% | 15 |
|
|
2020
Q1 | $1.68B | Sell |
30,160,095
-3,004,927
| -9% | -$184M | 0.88% | 13 |
|
|
2019
Q4 | $2.13B | Buy |
33,165,022
+1,914,708
| +6% | +$110M | 0.89% | 11 |
|
|
2019
Q3 | $1.59B | Buy |
31,250,314
+4,624,215
| +17% | +$217M | 0.71% | 20 |
|
|
2019
Q2 | $1.21B | Sell |
26,626,099
-1,645,847
| -6% | -$76.7M | 0.54% | 29 |
|
|
2019
Q1 | $1.35B | Buy |
28,271,946
+1,444,285
| +5% | +$71.9M | 0.62% | 26 |
|
|
2018
Q4 | $1.39B | Buy |
26,827,661
+2,827,484
| +12% | +$152M | 0.7% | 17 |
|
|
2018
Q3 | $1.56B | Sell |
24,000,177
-76,598
| -0.3% | -$4.55M | 0.54% | 28 |
|
|
2018
Q2 | $1.33B | Buy |
24,076,775
+8,303,421
| +53% | +$448M | 0.59% | 24 |
|
|
2018
Q1 | $998M | Buy |
15,773,354
+3,061,221
| +24% | +$197M | 0.45% | 39 |
|
|
2017
Q4 | $780M | Sell |
12,712,133
-1,918,062
| -13% | -$120M | 0.36% | 57 |
|
|
2017
Q3 | $933M | Sell |
14,630,195
-921,964
| -6% | -$53.8M | 0.44% | 35 |
|
|
2017
Q2 | $867M | Buy |
15,552,159
+5,108
| +0% | +$278K | 0.43% | 36 |
|
|
2017
Q1 | $846M | Buy |
15,547,051
+2,451,390
| +19% | +$134M | 0.44% | 40 |
|
|
2016
Q4 | $765M | Sell |
13,095,661
-4,711,825
| -26% | -$258M | 0.42% | 42 |
|
|
2016
Q3 | $961M | Sell |
17,807,486
-1,214,592
| -6% | -$78M | 0.54% | 35 |
|
|
2016
Q2 | $1.4B | Sell |
19,022,078
-2,952,017
| -13% | -$209M | 0.82% | 18 |
|
|
2016
Q1 | $1.4B | Sell |
21,974,095
-924,250
| -4% | -$58.3M | 0.84% | 16 |
|
|
2015
Q4 | $1.58B | Buy |
22,898,345
+1,920,712
| +9% | +$127M | 0.92% | 14 |
|
|
2015
Q3 | $1.24B | Buy |
20,977,633
+2,077,128
| +11% | +$132M | 0.77% | 18 |
|
|
2015
Q2 | $1.26B | Sell |
18,900,505
-1,184,589
| -6% | -$78.1M | 0.72% | 17 |
|
|
2015
Q1 | $1.3B | Buy |
20,085,094
+1,033,367
| +5% | +$64.7M | 0.74% | 18 |
|
|
2014
Q4 | $1.12B | Sell |
19,051,727
-745,703
| -4% | -$42.1M | 0.66% | 21 |
|
|
2014
Q3 | $1.01B | Buy |
19,797,430
+1,180,339
| +6% | +$59M | 0.61% | 23 |
|
|
2014
Q2 | $903M | Buy |
18,617,091
+2,163,100
| +13% | +$107M | 0.53% | 26 |
|
|
2014
Q1 | $855M | Sell |
16,453,991
-2,116,574
| -11% | -$113M | 0.51% | 26 |
|
|
2013
Q4 | $987M | Buy |
18,570,565
+6,133,127
| +49% | +$312M | 0.6% | 21 |
|
|
2013
Q3 | $576M | Sell |
12,437,438
-3,430,372
| -22% | -$151M | 0.38% | 47 |
|
|
2013
Q2 | $709M | Buy |
+15,867,810
| New | +$689M | 0.49% | 30 |
|
Other funds holding BMY
VCM
VPM
Ameriprise's BMY Position: Q1 2026 in Review
Ameriprise reduced its Bristol-Myers Squibb (BMY) stake by 5.7% in Q1 2026, selling an estimated $92.6M and leaving 26,470,718 shares worth $1.61B. The position accounts for 0.37% of the portfolio, ranked #46.
Ameriprise first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.13B in Q4 2019. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Ameriprise held 26,470,718 shares of Bristol-Myers Squibb worth $1.61B as of Q1 2026.
- Ameriprise sold 1,587,938 Bristol-Myers Squibb shares in Q1 2026, an estimated $92.6M.
- Bristol-Myers Squibb made up 0.37% of Ameriprise's portfolio in Q1 2026, its #46 holding.
- Ameriprise first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Ameriprise's Bristol-Myers Squibb position peaked at $2.13B in Q4 2019.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.